Medicare Part D & Prescription Drug Pricing | Medicare Policy Initiative

Skip to main content

Sustaining Medicare’s Stand-Alone Prescription Drug Plans (PDPs): Part 1—Why are PDP options declining for Medicare beneficiaries?

Beyond Insolvency: The Bigger Picture of Medicare’s 2026 Financial Outlook

Contract Year 2027 Medicare Advantage and Part D Proposed Rule

Drug Pricing in the Era of Trump 2.0

Policy options to cover anti-obesity drugs: Highlighting the Georgetown policy compendium as a resource

Did Changes From the Inflation Reduction Act Affect Medicare Beneficiaries’ Plan Decisions During Open Enrollment? Reflections From Two SHIP Counselors